Optimization of anemia treatment in hemodialysis patients via reinforcement learning
Anemia is a common complication characterized by a reduced concentration of hemoglobin (Hb) that occurs in over 90% of patients undergoing hemodialysis [1]. Hemodialysis is the most common treatment for patients in advanced stages of chronic kidney disease (CKD), particularly in its end state, commonly referred as end-stage renal disease (ESRD). In the last years the prevalence of ESRD has increased substantially, reaching more than 1000 per million population in most of the developed countries [2].
Source: Artificial Intelligence in Medicine - Category: Bioinformatics Authors: Pablo Escandell-Montero, Milena Chermisi, José M. Martínez-Martínez, Juan Gómez-Sanchis, Carlo Barbieri, Emilio Soria-Olivas, Flavio Mari, Joan Vila-Francés, Andrea Stopper, Emanuele Gatti, José D. Martín-Guerrero Source Type: research
More News: Anemia | Bioinformatics | Chronic Kidney Disease | Dialysis | Hemodialysis | Kidney Transplant | Learning | Universities & Medical Training | Urology & Nephrology